Literature DB >> 2351304

Major histocompatibility complex class II antigen (HLA-DR) expression by ileal epithelial cells in patients with seronegative spondylarthropathy.

C Cuvelier1, H Mielants, M De Vos, E Veys, H Roels.   

Abstract

Major histocompatibility complex molecules act as non-specific receptors for antigenic proteins and present them to T-cells. Presented antigen together with class II molecules activates antigen specific T-helper cells and may trigger a cellular immune response. The expression of HLA-DR antigens by epithelial cells was examined with an indirect peroxidase technique in ileal biopsies from 38 patients with seronegative spondylarthropathy and features of acute or chronic gut inflammation on biopsy, 14 patients with chronic inflammatory bowel disease, 10 rheumatic and 10 non-rheumatic controls. In acute ileitis, there was more HLA-DR expression in villous and crypt epithelial cells than in non-inflamed controls (p less than 0.01). In chronic inflammation and in chronic inflammatory bowel disease, class II antigens were more expressed in villus (p less than 0.02) and crypt epithelium (p less than 0.01). Strong HLA-DR expression in crypt epithelial cells was connected with active inflammation (p less than 0.02). These findings suggest binding of unknown enterobacterial or nutritional luminal antigens to HLA-DR antigens normally present in enterocytes. The enterocytes act as antigen presenting cells causing a local increase of targets for activated T-cells and trigger the gut inflammation responsible for the clinical symptoms of the seronegative spondylarthropathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351304      PMCID: PMC1378571          DOI: 10.1136/gut.31.5.545

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera.

Authors:  P W Bland; L G Warren
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

2.  Antigen presentation by epithelial cells of the rat small intestine. II. Selective induction of suppressor T cells.

Authors:  P W Bland; L G Warren
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

3.  HLA antigens in seronegative spondylarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation.

Authors:  H Mielants; E M Veys; R Joos; L Noens; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

4.  Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease.

Authors:  I Hirata; L L Austin; W H Blackwell; J R Weber; W O Dobbins
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

5.  Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory diseases of colon.

Authors:  G B McDonald; D P Jewell
Journal:  J Clin Pathol       Date:  1987-03       Impact factor: 3.411

6.  Repeat ileocolonoscopy in reactive arthritis.

Authors:  H Mielants; E M Veys; R Joos; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

7.  Histopathology of intestinal inflammation related to reactive arthritis.

Authors:  C Cuvelier; C Barbatis; H Mielants; M De Vos; H Roels; E Veys
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

8.  Familial aggregation in seronegative spondyloarthritis of enterogenic origin. A family study.

Authors:  H Mielants; E M Veys; R Joos; S Suykens; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

9.  Expression of HLA-DR antigens on epithelium associated with lymphoid tissue in the human gastrointestinal tract.

Authors:  J Spencer; T Finn; P G Isaacson
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

10.  Increased HLA-DR expression by enterocytes in children with celiac disease.

Authors:  F Arnaud-Battandier; N Cerf-Bensussan; R Amsellem; J Schmitz
Journal:  Gastroenterology       Date:  1986-11       Impact factor: 22.682

View more
  9 in total

1.  Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.

Authors:  I E A Hoffman; P Demetter; M Peeters; M De Vos; H Mielants; E M Veys; F De Keyser
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

2.  Subclinical gut inflammation in spondyloarthropathy patients is associated with upregulation of the E-cadherin/catenin complex.

Authors:  P Demetter; D Baeten; F De Keyser; M De Vos; N Van Damme; G Verbruggen; S Vermeulen; M Mareel; D Elewaut; H Mielants; E M Veys; C A Cuvelier
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

3.  MHC class I chain-like gene A (MICA) and its associations with inflammatory bowel disease and peripheral arthropathy.

Authors:  T R Orchard; A Dhar; J D Simmons; R Vaughan; K I Welsh; D P Jewell
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

4.  Induction of MHC class II gene products in rat intestinal epithelium during graft-versus-host disease and effects on the immune function of the epithelium.

Authors:  P W Bland; C V Whiting
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 5.  Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms.

Authors:  Jeroen Visser; Jan Rozing; Anna Sapone; Karen Lammers; Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

6.  Expression of T cell receptors alpha beta and gamma delta in the ileal mucosa of patients with Crohn's disease and with spondylarthropathy.

Authors:  C A Cuvelier; N De Wever; H Mielants; M De Vos; E M Veys; H Roels
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

7.  Altered expression of intestinal human leucocyte antigen D-related and immune signalling molecules in juvenile idiopathic arthritis.

Authors:  M Arvonen; P Vähäsalo; S Turunen; H M Salo; M Mäki; K Laurila; O Vaarala; T J Karttunen
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

8.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

Authors:  M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

9.  Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression.

Authors:  B Crotty; P Hoang; H R Dalton; D P Jewell
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.